Semaglutide is a prescription GLP-1 receptor agonist used in Australia to help manage type 2 diabetes and, at higher doses, chronic weight management. It is available as weekly injections (Ozempic, Wegovy) and a daily oral tablet (Rybelsus).

How does semaglutide help with weight loss?

Semaglutide mimics the GLP-1 hormone to reduce appetite, increase fullness, and slow stomach emptying, which helps people eat fewer calories and lose weight when combined with diet and lifestyle support.

Which semaglutide brands are approved in Australia?

TGA-approved brands are Ozempic (weekly injection for type 2 diabetes), Wegovy (weekly injection for chronic weight management), and Rybelsus (daily oral semaglutide for type 2 diabetes).

What are common semaglutide side effects?

The most common effects are nausea, vomiting, diarrhoea, constipation, abdominal discomfort, and reduced appetite. Serious but uncommon risks include pancreatitis, gallbladder problems, kidney injury, and severe dehydration.

What Is Semaglutide? Weight loss, diabetes and approved brand use Explained

Q: Is semaglutide legal in Australia?

Yes. Semaglutide is a prescription-only medicine in Australia. Access requires a valid script from an authorised prescriber, and supply is through Australian pharmacies.

Semaglutide in one minute

What it is: a GLP‑1 receptor agonist that mimics a natural gut hormone.
What it does: lowers blood glucose in type 2 diabetes; reduces appetite and helps weight loss at higher doses.
Forms in Australia: weekly injection (Ozempic, Wegovy) and daily oral tablet (Rybelsus).
Not a stimulant, steroid or amphetamine.

See how GLP‑1 works Ask an expert

Approved brands and what each is used for

Ozempic (weekly injection): TGA‑approved for glycaemic control in adults with type 2 diabetes. Learn more: Ozempic Australia Guide | Ozempic Cost | Ozempic Side Effects
Wegovy (weekly injection): TGA‑approved for chronic weight management in adults who meet criteria. Learn more: Wegovy Australia Guide | Wegovy Cost | Wegovy Side Effects
Rybelsus (oral tablet): TGA‑approved daily oral semaglutide for adults with type 2 diabetes. Learn more: Rybelsus Australia Guide | Rybelsus Cost | Rybelsus Side Effects

Note: Product brands differ by indication, dose range and form factor. Weight loss use is under Wegovy; diabetes control is under Ozempic and Rybelsus. Off‑label use should be discussed with a qualified prescriber.

Read the GLP‑1 Australia Guide

How semaglutide works (GLP‑1 explained)

GLP‑1 is a hormone released after eating. Semaglutide activates the same receptor to:

Increase glucose‑dependent insulin release
Reduce glucagon secretion
Slow gastric emptying to enhance fullness
Act on appetite centres in the brain to reduce hunger

The result: improved blood glucose in type 2 diabetes and, at higher weight‑management doses, fewer calories consumed and sustainable weight loss when paired with diet and activity support.

See benefits and evidence Get personalised guidance

What semaglutide is used for in Australia

Type 2 diabetes care

Improves HbA1c and fasting/post‑meal glucose
Low risk of hypoglycaemia when not used with insulin or sulfonylureas
Some GLP‑1 agents, including semaglutide, show cardiovascular benefit in people with type 2 diabetes and established cardiovascular disease

Chronic weight management

Supports clinically meaningful weight loss when combined with lifestyle interventions
Often improves waist circumference and markers of metabolic health

Explore condition‑specific guides: Semaglutide for Weight Loss • Semaglutide for Obesity • Semaglutide for Insulin Resistance • Semaglutide for Appetite Suppression • Semaglutide for PCOS

Compare weight loss injections

Who may be eligible

Type 2 diabetes: Adults where diet, exercise and/or prior medicines have not adequately controlled blood glucose. Ozempic and Rybelsus are diabetes‑labelled options.
Weight management: Adults meeting clinical criteria (e.g., BMI threshold and relevant comorbidities) may be considered for Wegovy with prescriber assessment.
Funding: Ozempic may be PBS‑subsidised for eligible type 2 diabetes indications. Wegovy and Rybelsus are typically private prescriptions. Confirm current status with your prescriber and pharmacist.

Prescription requirements in Australia

Safety, side effects and key warnings

Common effects (often improve over time): nausea, vomiting, diarrhoea, constipation, abdominal pain, reflux, headache, fatigue, decreased appetite.

Uncommon but important risks: pancreatitis, gallbladder problems, severe dehydration, kidney injury, possible worsening of diabetic retinopathy with rapid glucose improvement, ileus. GLP‑1 RAs have a class warning about thyroid C‑cell tumours in rodents; relevance to humans is uncertain.

Do not use if you have a personal/family history of medullary thyroid carcinoma or MEN2, a history of hypersensitivity to semaglutide, or if pregnant/breastfeeding unless specifically advised. Use with caution if you have pancreatitis history, significant GI disease, or advanced diabetic retinopathy. Hypoglycaemia risk increases when combined with insulin or sulfonylureas.

Seek urgent care for severe abdominal pain (especially radiating to the back), signs of gallbladder disease, persistent vomiting, signs of allergic reaction, or symptoms of severe dehydration.

Ask about side effects

Access and legality in Australia

Legal status: Prescription‑only medicine (Schedule 4). Scripts are written by authorised prescribers; dispensing occurs via Australian pharmacies.
Supply and shortages: Availability can fluctuate. Your prescriber or pharmacist can advise on current stock and alternatives.
Telehealth: Many Australians use telehealth for assessment and ongoing care. Ensure any provider uses Australian‑registered clinicians and scripts sent to Australian pharmacies.

Learn more: Is Semaglutide Legal in Australia? • Buy Semaglutide Australia: Safer Routes • Semaglutide Cost Australia

How telehealth access works

How semaglutide compares to similar options

Not sure which fits your situation?

Frequently asked questions

What is semaglutide in simple terms?

A GLP‑1 medicine that helps control blood sugar and, at higher doses, supports clinically significant weight loss.

Which brands contain semaglutide?

Ozempic (weekly injection, type 2 diabetes), Wegovy (weekly injection, weight management), and Rybelsus (oral tablet, type 2 diabetes).

How quickly might results show?

Gastrointestinal effects can appear in days; appetite changes often within 1–2 weeks; weight and HbA1c changes typically accrue over months. See: Results Timeline.

Is titration necessary?

Yes. Gradual dose increases help minimise side effects. See: Semaglutide Dosage Guide.

Can I use it just for appetite control?

Weight management use is under Wegovy with clinical criteria. Discuss risks, benefits and alternatives with a prescriber. See: Appetite Suppression.

What are the main risks?

GI effects are most common; rare risks include pancreatitis and gallbladder issues. Review: Side Effects Guide.

Is it legal to buy semaglutide online?

Only with a valid Australian prescription, dispensed by an Australian pharmacy. Learn more: Legal Status and Safer Buying Routes.

What should I do next?

Read our GLP‑1 overview and speak with a qualified prescriber if semaglutide may suit your goals. GLP‑1 Australia Guide.

Key takeaway

Semaglutide is a GLP‑1 medicine used in Australia for type 2 diabetes and chronic weight management under specific brands. It works by improving glucose control and reducing appetite. Appropriate dosing, safety screening and prescriber follow‑up are essential.

Ask a question about semaglutide

Get help from Peptide Help

Have questions about semaglutide, GLP‑1 options, costs or access in Australia? Send us a message and we’ll point you to clear, evidence‑based resources. We do not sell medications or provide prescriptions.